Tuttiquotidiani e completamente gratuito. Ogni giorno aggreghiamo notizie da oltre 100 testate e generiamo sintesi AI originali per te. Aiutaci a mantenere il servizio attivo con una piccola donazione, oppure diventa TQ Pro da solo 1€/mese.

From drought to demand: Biotech IPOs roar back with Kailera and Alamar

  • Posted on April 18, 2026
  • By Fortune
  • 0 Views
  • 1 min read
From drought to demand: Biotech IPOs roar back with Kailera and Alamar
From drought to demand: Biotech IPOs roar back with Kailera and Alamar

Strong demand for GLP-1 drugs and next-gen diagnostic testing is pulling investors back into life sciences, even as AI soaks up most venture dollars.
continue reading...

Author
Fortune

You May Also Like